Key result
Percutaneous ASD closure in children weighing ≤15 kg achieved a 94% device implantation rate with no major complications and a 15.4% minor complication rate.
Why the study?
Is transcatheter ASD closure safe and effective in children weighing ≤15 kg?
Observational (n=52)
Yes
Is transcatheter ASD closure safe and effective in children weighing ≤15 kg?
Percutaneous ASD closure is a safe and effective alternative to surgery in symptomatic children weighing ≤15 kg, though minor complications are more frequent with larger defects.
Answers are grounded in this paper and cite their sources.
Supports percutaneous ASD closure in children ≤15 kg; hypothesis-generating and requires randomized trials before practice change.
OBJECTIVE: To assess safety and efficacy of transcatheter atrial septal defect (ASD) closure in small children. BACKGROUND: Percutaneous closure of ASD is a well accepted alternative to surgery. Reported experience in small children remains, however, scarce. METHODS: Fifty-two children underwent percutaneous ASD closure at a weight < or =15 kg, in four Belgian tertiary referral paediatric cardiology centers. Indication for treatment, device implantation rate, procedural details, complication rate, residual shunt on echocardiography, and impact of procedure on symptoms were retrospectively analyzed. RESULTS: Mean age at procedure was 36 months (7-60), mean weight 13 kg (4.7-15). Associated cardiac lesions were seen in 21% of the patients and noncardiac in 32.7%. Most patients (69.2%) were symptomatic. Mean ASD size was 12 mm (range 5-20 mm). A device could be inserted in 49 patients (94%). No major complications occurred. Minor complications occurred in 8 patients (15.4%) including device embolization in 2, successfully treated with transcatheter retrieval and second device insertion. Mean follow-up reached 27 months (0.03-61.2). Residual shunt was absent, trivial, or small in 93% (n = 42) at latest follow-up. Clinical improvement was noted in 91.7% of the symptomatic patients. Minor complications were more frequent in the presence of large ASDs (>15 mm) but not in smaller babies (<10 kg). CONCLUSION: Patients < or =15 kg requiring ASD closure form a special population with high incidence of associated anomalies and medical conditions. For this particular set of patients, percutaneous closure is a valid alternative. Asymptomatic or mildly symptomatic children should be treated at a later age.
No takes yet. Share an insight, caveat, or question.
Panzer et al. (2006) conducted an observational in Secundum atrial septal defect (n=52). Percutaneous atrial septal defect closure was evaluated on Device implantation rate. Percutaneous ASD closure in children weighing ≤15 kg achieved a 94% device implantation rate with no major complications and a 15.4% minor complication rate.
Synapse has enriched 10 related papers. Consider them for comparative context: